Washington Post
@washingtonpost·2.8M subscribers·24.8K videos
Pfizer had clues its drug could prevent Alzheimer’s. What happened?
Posted
June 5, 2019
Views
19,434
Likes
331
Comments
74
Engagement
June 5, 2019
19,434
331
74
2.08%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
2:22Now PlayingThe company’s rheumatoid arthritis drug appeared to reduce the risk of getting Alzheimer’s disease by 64 percent. The Washington Post’s Chris Rowland explains why Pfizer did not pursue it. Read moreSubscribe to The Washington Post on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
